Search research articles
Contact Us
Filters
Showing results (491-500 of 609) with videos related to
Page
of 61
Sort By:
Journal of Clinical Pharmacology
|
May 12, 2024
Pooled Population Pharmacokinetic Analysis and Dose Recommendations for Ciprofloxacin in Intensive Care Unit Patients with Obesity
Koen P van Rhee, Roger J M Brüggemann, Jason A Roberts, et al.
Journal of Paediatrics and Child Health
|
December 27, 2025
Prolonged Versus Intermittent Beta-Lactam Antibiotic Infusions in Paediatric Critical Care: A Systematic Review and Meta-Analysis
Kirsty O'Keefe, Kerina J Denny, Renate Le Marsney, et al.
The Journal of Antimicrobial Chemotherapy
|
September 10, 2024
Population pharmacokinetics of unbound cefazolin in infected hospitalized patients requiring intermittent high-flux haemodialysis: can a three-times-weekly post-dialysis dosing regimen provide optimal treatment?
Carleigh Duke, Suzanne L Parker, Betty B Zam, et al.
Jac-Antimicrobial Resistance
|
May 28, 2026
Challenges and drivers in the implementation of current practices in outpatient parenteral antimicrobial therapy: an international survey
Solomon Ahmed Mohammed, Jason A Roberts, David Nicolás, et al.
Scientific Reports
|
January 28, 2025
Evaluation of ampicillin plus ceftobiprole combination therapy in treating Enterococcus faecalis infective endocarditis and bloodstream infection
Simone Giuliano, Jacopo Angelini, Floriana Campanile, et al.
The Journal of Antimicrobial Chemotherapy
|
June 27, 2023
Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic study
Danny Tsai, Betty B Zam, Carleigh Tongs, et al.
Implementation Science Communications
|
March 25, 2021
Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study
Erin F Barreto, Andrew D Rule, Mohammad H Alshaer, et al.
Antimicrobial Agents and Chemotherapy
|
March 8, 2017
Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model
Phillip J Bergen, Jürgen B Bulitta, Carl M J Kirkpatrick, et al.
British Journal of Clinical Pharmacology
|
July 21, 2021
Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementation
Indy Sandaradura, Jan-Willem Alffenaar, Menino O Cotta, et al.
Antimicrobial Agents and Chemotherapy
|
October 23, 2019
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients
Rajbharan Yadav, Phillip J Bergen, Kate E Rogers, et al.
Page
of 61
Search research articles
Search
Showing results (491-500 of 609) with videos related to
Sort By:
Page
of 61
Journal of Clinical Pharmacology
|
May 12, 2024
Pooled Population Pharmacokinetic Analysis and Dose Recommendations for Ciprofloxacin in Intensive Care Unit Patients with Obesity
Koen P van Rhee, Roger J M Brüggemann, Jason A Roberts, et al.
Journal of Paediatrics and Child Health
|
December 27, 2025
Prolonged Versus Intermittent Beta-Lactam Antibiotic Infusions in Paediatric Critical Care: A Systematic Review and Meta-Analysis
Kirsty O'Keefe, Kerina J Denny, Renate Le Marsney, et al.
The Journal of Antimicrobial Chemotherapy
|
September 10, 2024
Population pharmacokinetics of unbound cefazolin in infected hospitalized patients requiring intermittent high-flux haemodialysis: can a three-times-weekly post-dialysis dosing regimen provide optimal treatment?
Carleigh Duke, Suzanne L Parker, Betty B Zam, et al.
Jac-Antimicrobial Resistance
|
May 28, 2026
Challenges and drivers in the implementation of current practices in outpatient parenteral antimicrobial therapy: an international survey
Solomon Ahmed Mohammed, Jason A Roberts, David Nicolás, et al.
Scientific Reports
|
January 28, 2025
Evaluation of ampicillin plus ceftobiprole combination therapy in treating Enterococcus faecalis infective endocarditis and bloodstream infection
Simone Giuliano, Jacopo Angelini, Floriana Campanile, et al.
The Journal of Antimicrobial Chemotherapy
|
June 27, 2023
Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic study
Danny Tsai, Betty B Zam, Carleigh Tongs, et al.
Implementation Science Communications
|
March 25, 2021
Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study
Erin F Barreto, Andrew D Rule, Mohammad H Alshaer, et al.
Antimicrobial Agents and Chemotherapy
|
March 8, 2017
Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model
Phillip J Bergen, Jürgen B Bulitta, Carl M J Kirkpatrick, et al.
British Journal of Clinical Pharmacology
|
July 21, 2021
Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementation
Indy Sandaradura, Jan-Willem Alffenaar, Menino O Cotta, et al.
Antimicrobial Agents and Chemotherapy
|
October 23, 2019
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients
Rajbharan Yadav, Phillip J Bergen, Kate E Rogers, et al.
Page
of 61